An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study
Crossref DOI link: https://doi.org/10.1038/s41598-024-69279-6
Published Online: 2024-08-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shiraishi, Chihiro
Kato, Hideo
Ogura, Toru
Iwamoto, Takuya
Text and Data Mining valid from 2024-08-06
Version of Record valid from 2024-08-06
Article History
Received: 13 November 2023
Accepted: 2 August 2024
First Online: 6 August 2024
Competing interests
: The authors declare no competing interests.